PharmD Info

A forum for Indian Pharmacy Professionals

Search found 13 matches

 Return to the advanced search

Steps for conducting any pharmacoeconomic analysis are as follows: (1) defining the problem, (2) determining the study's perspective, (3) determining the alternatives and outcomes, (4) selecting the appropriate pharmacoeconomic method, (5) placing monetary values on the outcomes, (6) identifying stu...

Re: Medicine Risk Management - Case Study

 by Solomon Benny ¦  07 Oct 2017, 12:04 ¦  Forum: Pharmacotherapy Cases ¦  Topic: Medicine Risk Management - Case Study ¦  Replies: 41 ¦  Views: 35118

11.pottasium chloride 10 Meq are avaialable as otc .
high concentrations of pot chloride are not safe to keep in clinical araes..cz unintentional administration can cause life threatening conditions

Re: Medicine Risk Management - Case Study

 by Solomon Benny ¦  07 Oct 2017, 11:58 ¦  Forum: Pharmacotherapy Cases ¦  Topic: Medicine Risk Management - Case Study ¦  Replies: 41 ¦  Views: 35118

10 .pottasium chloride infusion should contain 10 -20 mmol max possible dose..with 0.9% sodium chloride
increase in dose can cause electrolyte imbalance .hperkalemia .also arrhythmic complications

Re: Medicine Risk Management - Case Study

 by Solomon Benny ¦  07 Oct 2017, 11:49 ¦  Forum: Pharmacotherapy Cases ¦  Topic: Medicine Risk Management - Case Study ¦  Replies: 41 ¦  Views: 35118

9.infection at the site of injection .chances of sysytemic infection . allergic reactions are fast . reddness ,pain ,swelling at site occurs .damage to blood vessels ,phlebitis and inflammation of veins . if air gets trapped in syringe : air embolism occurs . blood clots are possible to form

Re: Medicine Risk Management - Case Study

 by Solomon Benny ¦  07 Oct 2017, 11:38 ¦  Forum: Pharmacotherapy Cases ¦  Topic: Medicine Risk Management - Case Study ¦  Replies: 41 ¦  Views: 35118

pottassium chloride for patients with 2.4 mmol should be administerd with 10 Meq /mol.

too much pottasium can aggrevate arrythmic problems.

Re: Medicine Risk Management - Case Study

 by Solomon Benny ¦  07 Oct 2017, 11:05 ¦  Forum: Pharmacotherapy Cases ¦  Topic: Medicine Risk Management - Case Study ¦  Replies: 41 ¦  Views: 35118

6.digoxin dose for atrial fibrillation: dose: iv 8 to 12 mg mcg/kg tablets 10 to 15 mcg/kg oral solution 10 to 15 mcg/kg maintanence dose: iv 2.4 to 3.6 mcg /kg tablets 3.4 to 5.1 mcg/kg orl solution 3.0 to 4.5 mcg/kg here the maintenece dose given is too high(625 mcg)...should reduce it.(avg weight...

Re: Medicine Risk Management - Case Study

 by Solomon Benny ¦  07 Oct 2017, 11:02 ¦  Forum: Pharmacotherapy Cases ¦  Topic: Medicine Risk Management - Case Study ¦  Replies: 41 ¦  Views: 35118

6.digoxin dose for atrial fibrillation: dose: iv 8 to 12 mg mcg/kg tablets 10 to 15 mcg/kg oral solution 10 to 15 mcg/kg maintanence dose: iv 2.4 to 3.6 mcg /kg tablets 3.4 to 5.1 mcg/kg orl solution 3.0 to 4.5 mcg/kg here the maintenece dose given is too high(625 mcg)...should reduce it.(avg weight...

Re: Medicine Risk Management - Case Study

 by Solomon Benny ¦  07 Oct 2017, 11:00 ¦  Forum: Pharmacotherapy Cases ¦  Topic: Medicine Risk Management - Case Study ¦  Replies: 41 ¦  Views: 35118

6.digoxin dose for atrial fibrillation: dose: iv 8 to 12 mg mcg/kg tablets 10 to 15 mcg/kg oral solution 10 to 15 mcg/kg maintanence dose: iv 2.4 to 3.6 mcg /kg tablets 3.4 to 5.1 mcg/kg orl solution 3.0 to 4.5 mcg/kg here the maintenece dose given is too high(625 mcg)...should reduce it.(avg weight...

Re: Medicine Risk Management - Case Study

 by Solomon Benny ¦  07 Oct 2017, 10:49 ¦  Forum: Pharmacotherapy Cases ¦  Topic: Medicine Risk Management - Case Study ¦  Replies: 41 ¦  Views: 35118

2.drug interactions :digoxin and warfarin _loss of anticoagulant control . this is a major pharmaceutical problem 3.patient is dehydrated % also suffering from uti,so she should drink lots of fluids, digoxin should be taken for only 5 days a week. avoid chances of bleeding , using equipments for uri...

Re: Medicine Risk Management - Case Study

 by Solomon Benny ¦  07 Oct 2017, 10:47 ¦  Forum: Pharmacotherapy Cases ¦  Topic: Medicine Risk Management - Case Study ¦  Replies: 41 ¦  Views: 35118

2.drug interactions :digoxin and warfarin _loss of anticoagulant control . this is a major pharmaceutical problem 3.patient is dehydrated % also suffering from uti,so she should drink lots of fluids, digoxin should be taken for only 5 days a week. avoid chances of bleeding , using equipments for uri...

Refer pdf

Economic questions vise notes

Refer pdf and pharm d guru also

ICH GCP CDSCO

ICH GCP CDSCO guidelines

Various phases of CT

Various phases of CT in detail

PharmD Info - Highlights